Citadel Advisors’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Sell
214,320
-111,984
-34% -$1.83M ﹤0.01% 5171
2025
Q4
$4.21M Buy
+326,304
New +$3.46M ﹤0.01% 4559
2025
Q2
Sell
-216,588
Closed -$1.61M 13565
2025
Q1
$1.87M Buy
216,588
+187,365
+641% +$1.33M ﹤0.01% 5658
2024
Q4
$196K Sell
29,223
-39,736
-58% -$295K ﹤0.01% 10497
2024
Q3
$496K Sell
68,959
-32,528
-32% -$300K ﹤0.01% 8271
2024
Q2
$1.05M Sell
101,487
-75,925
-43% -$759K ﹤0.01% 6476
2024
Q1
$1.78M Sell
177,412
-401,087
-69% -$4.31M ﹤0.01% 5749
2023
Q4
$8.83M Buy
578,499
+50,499
+10% +$697K ﹤0.01% 3011
2023
Q3
$7.39M Buy
528,000
+527,817
+288,425% +$7.98M ﹤0.01% 3080
2023
Q2
$2.42K Buy
+183
New +$2.49K ﹤0.01% 13782
2023
Q1
Sell
-998,505
Closed -$17.7M 15031
2022
Q4
$14.9M Buy
998,505
+837,261
+519% +$14.6M ﹤0.01% 2308
2022
Q3
$3.21M Buy
161,244
+27,765
+21% +$688K ﹤0.01% 4672
2022
Q2
$2.73M Sell
133,479
-81,021
-38% -$2M ﹤0.01% 4936
2022
Q1
$6.51M Buy
214,500
+134,846
+169% +$5.27M ﹤0.01% 3672
2021
Q4
$3.26M Buy
79,654
+67,270
+543% +$2.8M ﹤0.01% 5169
2021
Q3
$525K Sell
12,384
-21,098
-63% -$1.04M ﹤0.01% 9743
2021
Q2
$1.77M Sell
33,482
-113,824
-77% -$5.66M ﹤0.01% 6896
2021
Q1
$6.53M Sell
147,306
-132,369
-47% -$6.53M ﹤0.01% 3726
2020
Q4
$13.4M Sell
279,675
-233,895
-46% -$11.3M ﹤0.01% 2257
2020
Q3
$24M Sell
513,570
-86,465
-14% -$4.24M 0.01% 1418
2020
Q2
$27M Buy
600,035
+335,373
+127% +$13M 0.01% 1241
2020
Q1
$7.72M Buy
264,662
+118,571
+81% +$4.41M ﹤0.01% 2167
2019
Q4
$6.96M Sell
146,091
-144,843
-50% -$6.27M ﹤0.01% 2647
2019
Q3
$11M Sell
290,934
-60,995
-17% -$2.38M 0.01% 2105
2019
Q2
$15M Buy
351,929
+200,354
+132% +$9.49M 0.01% 1703
2019
Q1
$8.03M Sell
151,575
-307,457
-67% -$17.7M ﹤0.01% 2335
2018
Q4
$27.1M Buy
459,032
+135,086
+42% +$7.46M 0.01% 999
2018
Q3
$17.7M Buy
323,946
+288,893
+824% +$16M 0.01% 1508
2018
Q2
$1.88M Sell
35,053
-331,861
-90% -$17.4M ﹤0.01% 4208
2018
Q1
$17.9M Buy
366,914
+190,952
+109% +$8.1M 0.01% 1219
2017
Q4
$5.96M Buy
+175,962
New +$6.16M ﹤0.01% 2273
2017
Q3
Sell
-49,798
Closed -$1.7M 7719
2017
Q2
$1.78M Sell
49,798
-27,262
-35% -$919K ﹤0.01% 3326
2017
Q1
$2.24M Sell
77,060
-47,092
-38% -$1.31M ﹤0.01% 2947
2016
Q4
$2.99M Sell
124,152
-208,260
-63% -$5.69M ﹤0.01% 2503
2016
Q3
$10.3M Sell
332,412
-408,398
-55% -$12.9M 0.01% 1327
2016
Q2
$21.7M Buy
740,810
+210,842
+40% +$6.31M 0.02% 727
2016
Q1
$16.3M Buy
529,968
+437,388
+472% +$11.3M 0.02% 874
2015
Q4
$2.48M Sell
92,580
-486,748
-84% -$13.5M ﹤0.01% 2522
2015
Q3
$15.8M Sell
579,328
-483,912
-46% -$13.3M 0.02% 1052
2015
Q2
$29.3M Buy
1,063,240
+210,042
+25% +$5.09M 0.03% 782
2015
Q1
$18.2M Buy
853,198
+172,340
+25% +$2.94M 0.02% 1028
2014
Q4
$12.8M Buy
680,858
+255,012
+60% +$5.46M 0.01% 1227
2014
Q3
$9.31M Buy
425,846
+352,558
+481% +$9.42M 0.01% 1423
2014
Q2
$2.37M Sell
73,288
-37,990
-34% -$1.16M ﹤0.01% 2576
2014
Q1
$3.19M Sell
111,278
-78,290
-41% -$2.59M ﹤0.01% 2169
2013
Q4
$7.46M Buy
189,568
+74,360
+65% +$2.58M 0.01% 1401
2013
Q3
$4.02M Sell
115,208
-27,794
-19% -$859K 0.01% 1752
2013
Q2
$3.23M Buy
+143,002
New +$3.04M 0.01% 1997

Other funds holding HLF

Citadel Advisors's HLF Position: Q1 2026 in Review

Citadel Advisors reduced its Herbalife (HLF) stake by 34% in Q1 2026, selling an estimated $1.83M and leaving 214,320 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5171.

Citadel Advisors first reported a position in HLF in Q2 2013 and has held it in 48 quarters since. The position peaked at $29.3M in Q2 2015. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Citadel Advisors held 214,320 shares of Herbalife worth $3.15M as of Q1 2026.
  • Citadel Advisors sold 111,984 Herbalife shares in Q1 2026, an estimated $1.83M.
  • Herbalife made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5171 holding.
  • Citadel Advisors first reported a position in Herbalife in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Herbalife position peaked at $29.3M in Q2 2015.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.